TVTX
Citigroup reiterates Travere Therapeutics Inc (TVTX) rating to a Buy
Travere Therapeutics Inc’s recently made public that its SVP, CHIEF ACCOUNTING OFFICER Calvin Sandra unloaded Company’s shares for reported $2.42 ...
Travere Therapeutics Inc (TVTX) gets rating Reiterated from Citigroup
Travere Therapeutics Inc’s filing revealed that its SVP, CHIEF ACCOUNTING OFFICER Calvin Sandra unloaded Company’s shares for reported $2.42 million ...
TVTX (Travere Therapeutics Inc) may reap gains as insiders became active recently
In a filing, Travere Therapeutics Inc revealed its SVP, CHIEF ACCOUNTING OFFICER Calvin Sandra unloaded Company’s shares for reported $2.42 ...
Recent Insider Activity Suggests Potential Gains for Travere Therapeutics Inc (TVTX)
Travere Therapeutics Inc’s recently made public that its SVP, CHIEF ACCOUNTING OFFICER Calvin Sandra unloaded Company’s shares for reported $2.42 ...
The Attractiveness of Investing In Travere Therapeutics Inc (TVTX) is Growing
Travere Therapeutics Inc’s recent filing unveils that its Officer SANDRA CALVIN acquired Company’s shares for reported $2.42 million on Nov ...
Travere Therapeutics Inc [TVTX] CHIEF EXECUTIVE OFFICER makes an insider purchase of 92,872 shares worth 2.82 million.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
